First, let’s take a look at HSBC’s financials. Like most banks, HSBC generates revenue from fees and interest on loans. Despite the dip in performance during the Covid-19 pandemic, the bank seems to have rebounded nicely. Its net income in 2021 surpassed its 2018 level, and it has remained strong even in the face of competition from fintech players and cryptocurrencies.
On the valuation front, HSBC seems attractive at first glance. Its P/E ratio, Price to Sales, Price to Book, and Price to Cash flow ratios are all reasonable compared to the sector average. This makes it a good value buy. However, it’s essential to consider the risks associated with doing business in China.
China’s autocratic government demands absolute loyalty and obedience from companies operating within its borders. HSBC has already experienced the consequences of displeasing China, including lost business relationships, fines, and public denigration. Despite this, HSBC has decided to double down on investments in China, which may not be a wise move in the long term.
China’s economy faces both short-term and long-term risks. Factors like the housing crisis, rapidly aging population, and looming debt crisis could have a significant impact on the Chinese economy for decades. Moreover, China’s autocratic nature poses additional risks for HSBC. The Chinese government may force the bank to engage in activities that serve its interests, and these mandates can change unpredictably.
Furthermore, operating in China exposes HSBC to geopolitical risks. If the Chinese economy falters, the government may take measures to ensure foreign companies remain in the country, potentially trapping HSBC. Similar to Russia’s approach, China may make it expensive for companies to leave, leading to potential financial consequences.
HSBC had an opportunity to mitigate these risks when a takeover attempt was made, which could have forced the bank to give up its business in China and Hong Kong. However, the deal was rejected. To avoid these risks, HSBC should consider selling its China and Hong Kong operations and focus on growth in other Asian markets.
Selling to Ping An Insurance Group, which showed interest in the past, could be a win-win situation. HSBC would rid itself of the risks associated with operating in China while maintaining its presence and growth in the rest of Asia. This would be a smart move in the long run, as doing business with an autocratic China comes with insidious costs.
Of course, there are risks to this sell thesis. HSBC might find a way to cut its losses in China and Hong Kong, which would be lucrative for the bank. Alternatively, China could reliably liberalize, improving the investment prospects for HSBC.
In conclusion, while HSBC may seem like an attractive blue chip stock, its expansion into China brings significant risks. Until the bank shows a willingness to sell its China and Hong Kong operations, it’s better to consider it a sell for the long term